文献速递糖尿病

英国全国性研究:1型糖尿病合并COVID-19住院患者的临床特征与重症风险因素

A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection.
PubMed 文献 · Diabetologia · 2021-05-08

该研究基于英国全国性审计数据,回顾性分析了196例1型糖尿病合并COVID-19住院成人,发现年龄≥55岁、较高BMI、较差肾功能及存在微血管并发症与死亡和/或入住重症监护室风险正相关,而55岁以下无血管并发症者重症风险很低。

要点

  • 年龄<55岁且无微血管或大血管并发症的1型糖尿病合并COVID-19住院患者重症风险很低。
  • BMI、血清肌酐水平及存在≥1种微血管并发症与重症风险独立正相关。
  • 入院时糖尿病酮症酸中毒患病率为29%。

核心结论

  • 在英国1型糖尿病合并COVID-19住院成人中,较高BMI、较差肾功能及存在微血管并发症与死亡和/或入住AICU风险增加相关。
  • 55岁以下且无微血管或大血管并发症的1型糖尿病患者重症COVID-19风险很低。

研究设计与样本

  • 主要结局为严重COVID-19,定义为院内死亡和/或入住成人重症监护室(AICU)。
  • 采用逻辑回归模型生成年龄校正的OR值。

主要发现

  • 最终数据集纳入196例成人,男性55%,白人70%,平均(SD)年龄62(19)岁,BMI 28.3(7.3)kg/m2,最近记录的HbA1c为76(31)mmol/mol [9.1(5.0)%]。
  • 既存微血管疾病患病率为56%,大血管疾病患病率为39%。
  • 入院时糖尿病酮症酸中毒患病率为29%。
  • 68例患者(35%)死亡或入住AICU。
  • 年龄<55岁、55-74岁和≥75岁患者的死亡比例分别为7%、38%和38%。

关键数值与推荐

  • 严重COVID-19定义为院内死亡和/或入住成人重症监护室(AICU)。

临床怎么用

  • 对1型糖尿病合并COVID-19住院患者,应评估BMI、肾功能及微血管并发症以识别重症高危人群。
  • 55岁以下且无微血管或大血管并发症的1型糖尿病患者重症风险很低,可据此进行风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this work was to describe the clinical characteristics of adults with type 1 diabetes admitted to hospital and the risk factors associated with severe coronavirus disease-2019 (COVID-19) in the UK. METHODS: A retrospective cohort study was performed using data collected through a nationwide audit of people admitted to hospital with diabetes and COVID-19, conducted by the Association of British Clinical Diabetologists from March to October 2020. Prespecified demographic, clinical, medication and laboratory data were collected from the electronic and paper medical record systems of the participating hospitals by local clinicians. The primary outcome of the study, severe COVID-19, was defined as death in hospital and/or admission to the adult intensive care unit (AICU). Logistic regression models were used to generate age-adjusted ORs. RESULTS: Forty UK centres submitted data. The final dataset included 196 adults who were admitted to hospital and had both type 1 diabetes and COVID-19 on admission (male sex 55%, white 70%, with mean [SD] age 62 [19] years, BMI 28.3 [7.3] kg/m2 and last recorded HbA1c 76 [31] mmol/mol [9.1 (5.0)%]). The prevalence of pre-existing microvascular disease and macrovascular disease was 56% and 39%, respectively. The prevalence of diabetic ketoacidosis on admission was 29%. A total of 68 patients (35%) died or were admitted to AICU. The proportions of people that died were 7%, 38% and 38% of those aged <55, 55-74 and ≥75 years, respectively. BMI, serum creatinine levels and having one or more microvascular complications were positively associated with the primary outcome after adjusting for age. CONCLUSIONS/INTERPRETATION: In people with type 1 diabetes and COVID-19 who were admitted to hospital in the UK, higher BMI, poorer renal function and presence of microvascular complications were associated with greater risk of death and/or admission to AICU. Risk of severe COVID-19 is reassuringly very low in people with type 1 diabetes who are under 55 years of age without microvascular or macrovascular disease. IN PEOPLE WITH TYPE 1 DIABETES AND COVID-19 ADMITTED TO HOSPITAL IN THE UK, BMI AND ONE OR MORE MICROVASCULAR COMPLICATIONS HAD A POSITIVE ASSOCIATION AND LOW SERUM CREATINE LEVELS HAD A NEGATIVE ASSOCIATION WITH DEATH/ADMISSION TO INTENSIVE CARE UNIT AFTER ADJUSTING FOR AGE.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ruan Y, Ryder REJ, De P, et al. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection. Diabetologia. 2021. PMID: 33966090. doi:10.1007/s00125-021-05463-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。